Lilly is offering its AI models that can help predict a drug's behavior to biotechs, in return for being able to use those ...

STAT MINI As a part of STAT's 10-year anniversary, we’ve launched a limited-edition crossword — the STAT Mini! With a new ...

Despite high price tags, the Wegovy and Zepbound obesity drugs are considered to be cost-effective, according to a new ...

BioNTech presented data showing that the same treatment was also effective in treating triple negative breast cancer last ...

Lilly is opening up its proprietary AI models to biotech companies that want to use them to jumpstart their science.

In its first decade, STAT has led the way in charting seismic events in health and medicine. To mark our 10-year anniversary, ...

Health care is already a team sport between humans and machines — but right now, we’re all playing it badly,” writes ...

By mixing politics with vaccines, Florida is playing with fire,” warn health department directors from Dallas and Columbus, ...

Men die five years earlier than women, a gap that's only grown in the last few decades. Why aren't we doing more to fix it?

Novartis said it would buy Tourmaline Bio in a deal worth $1.4 billion, building out its pipeline with a promising heart ...

HHS Secretary Robert F. Kennedy Jr.’s aggressive moves to change U.S. vaccine policy may be putting him at odds with ...

Fulmer updated her LinkedIn profile in early September to say that she is now a senior director of health policy at Mayo ...